How can I effectively monitor for potential complications in patients with hypertrophic cardiomyopathy in a primary care setting?

In primary care, effective monitoring for potential complications in patients with hypertrophic cardiomyopathy (HCM) involves regular clinical assessment focusing on symptoms and signs that may indicate disease progression or complications such as arrhythmias and heart failure. This includes asking about palpitations, syncope or presyncope, breathlessness, and oedema, as these may signal arrhythmias or worsening cardiac function. Checking the pulse rate and rhythm is essential, and if arrhythmia is suspected, arranging a 12-lead ECG or ambulatory ECG monitoring is recommended. Monitoring for signs of fluid overload such as raised jugular venous pressure, peripheral oedema, and lung crepitations should also be performed.

Functional capacity should be assessed using tools like the New York Heart Association (NYHA) classification to evaluate the impact on daily activities. Cognitive and psychological status, including screening for anxiety and depression, should be part of routine care. Medication review and monitoring for side effects, as well as renal function tests every 6 months, are important to ensure safe and effective treatment.

Patients should be offered annual influenza vaccination and a once-only pneumococcal vaccination to reduce infection risk. Nutritional status should be assessed, with dietetic referral considered for underweight or obese patients. Women of childbearing age require advice on contraception and pregnancy, with specialist referral if pregnancy is planned or occurs. A clear care plan including symptom monitoring, medication management, and access to specialist services should be established and regularly updated.

Referral to cardiology is indicated if there are signs of syncope not explained by other causes, suspected ventricular arrhythmias, or if the patient’s condition deteriorates. Structured follow-up intervals should be individualized but at least every 6 months if stable, with shorter intervals if clinical status or treatment changes. This approach aligns with heart failure monitoring principles and multidisciplinary care models, which are applicable to HCM management in primary care.

Summary of key monitoring actions in primary care for HCM:

• Regular symptom and sign assessment including palpitations, syncope, breathlessness, oedema.
• Pulse and rhythm check; ECG if arrhythmia suspected.
• Functional capacity assessment (e.g., NYHA class).
• Psychological screening and cognitive assessment.
• Medication review and renal function monitoring every 6 months.
• Vaccinations: annual influenza and once-only pneumococcal.
• Nutritional assessment and dietetic referral if needed.
• Contraception and pregnancy advice for women of childbearing age.
• Clear care plan with access to specialist cardiology services.
• Referral for specialist assessment if syncope, arrhythmia, or clinical deterioration occurs.

This monitoring strategy helps detect complications early and ensures timely specialist involvement, optimizing patient outcomes in hypertrophic cardiomyopathy within the primary care setting.

¹,²